Universal Health stock trades 28.7 percent below its yearly high

Published on 10/04/2026 at 21:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Universal Health stock posted Q2 revenue of USD 4.64 billion on July 28, 2026. Adjusted EPS reached USD 5.98 versus USD 5.94 consensus, while analysts kept a Hold view.

Flatlay mit Aktienzertifikat, ISIN-Karte, Stethoskop und medizinischen Utensilien — Flatlay mit Aktienzertifikat und ISIN-Karte zeigt Universal Health, Aktie ISIN US9139031002, dazu Stethoskop und Erste-Hilfe-Set, Illustration mit AI erstellt.

Universal Health Services, Inc. (ISIN US9139031002) closed at USD 175.72 on the NYSE on October 2, 2026, down 28.7 percent from its 52-week high of USD 246.33. The latest operating signal came from the company’s Q2 2026 results, which showed revenue growth alongside a quarterly earnings beat.

Q2 revenue reached USD 4.64 billion

According to MarketBeat in its October 2026 coverage, Universal Health Services reported Q2 revenue of USD 4.64 billion for the quarter ended June 30, 2026. Revenue increased 8.3 percent from the same period a year earlier and exceeded the USD 4.58 billion analyst estimate.

The same report said adjusted EPS reached USD 5.98, compared with a USD 5.94 consensus estimate and USD 5.35 in the prior-year quarter. That combination gives the stock a measurable earnings anchor even as the share price remains well below its yearly peak.

Operating growth supports the earnings case

The Q2 earnings call added operating detail. Fortune reported that adjusted EPS grew 12 percent year over year to USD 5.98, while adjusted EBITDA less noncontrolling interests rose 5 percent to USD 678 million.

Fortune also reported an 8.2 percent increase in same-facility acute-care revenue during Q2 2026. Revenue per adjusted admission increased 3.0 percent on a reported basis, or 2.7 percent excluding out-of-period Medicaid supplemental benefits.

Analysts see room above USD 175.72

Consensus data point to a divided but measurable valuation framework. MarketBeat lists six Buy ratings and twelve Hold ratings, producing a Hold consensus among 18 analysts.

Yahoo Finance lists an average analyst target of USD 194.35, with targets from USD 166.00 to USD 290.00. The average target is 10.6 percent above the October 2 closing price, placing the Q2 earnings trend against a share price that is 28.7 percent below the 52-week high.

Universal Health stock stays below its yearly high

Universal Health stock closed at USD 175.72 on October 2, 2026, with a market capitalization of USD 10.6 billion and a 52-week range of USD 140.08 to USD 246.33. The Q2 revenue beat and double-digit adjusted EPS growth provide the central operating measures for assessing the gap between the stock and its yearly high.